| | Exo | MVs | ABs | LOs |
| Size (diameter) | 30-100 nm [19] | 100-1000 nm [3, 19, 30] | 50-500 nm [32] | 1-10 μm [9, 33] | Flotation density | 1.10-1.21 g/mL | NA | 1.16-1.28 g/mL | NA | Morphology | “cup-shaped” | Various shapes | Heterogeneous [3, 32] | Large size - Various shapes | Lipid composition | Cholesterol, ceramide, sphingomyelin, low phosphatidylserine exposure, lipid rafts | High phosphatidylserine exposure, cholesterol [20, 28, 34] | High phosphatidylserine exposure | High phosphatidylserine exposure, cholesterol | Protein markers | Alix, CD63, CD9, CD81 [17, 35] | Selectins, integrins, CD40, MMP | Histones [32] | ARF6, CK18, GAPDH, MMP, oncogenic proteins complexes [31, 33, 36] | Site of origin | MVEs [1] or MVBs [17] | Plasma membrane | - | Plasma membrane | Mode of extracellular release | Exocytosis of MVEs [23] | Budding/blebbing of the plasma membrane [28] | Cell shrinkage and death | Budding from the plasma membrane [9, 33] | Composition
| Proteins, miRNA, mRNA | Proteins, miRNA, mRNA [8] | Proteins, DNA [32], miRNA, RNA [8] | Proteins, miRNA, mRNA, DNA [36, 37] |
|
|
MVs, microvesicles; ABs, apoptotic blebs; LOs, large oncosomes; MVEs, multivesicular endosomes; MVBs, multivesicular bodies; MMP, metalloproteinases; NA, not known.
|